期刊
MOUNT SINAI JOURNAL OF MEDICINE
卷 79, 期 2, 页码 169-189出版社
WILEY
DOI: 10.1002/msj.21302
关键词
chronic kidney disease; de novo malignancy; immunization; liver transplantation; long-term outcome; new-onset diabetes mellitus; osteoporosis; posttransplant metabolic syndrome; posttransplant quality of life; pregnancy
Liver transplantation is a life-saving therapy for patients with end-stage liver disease, acute liver failure, and liver tumors. Over the past 4 decades, improvements in surgical techniques, peritransplant intensive care, and immunosuppressive regimens have resulted in significant improvements in short-term survival. Focus has now shifted to addressing long-term complications and improving quality of life in liver recipients. These include adverse effects of immunosuppression; recurrence of the primary liver disease; and management of diabetes, hypertension, dyslipidemia, obesity, metabolic syndrome, cardiovascular disease, renal dysfunction, osteoporosis, and de novo malignancy. Issues such as posttransplant depression, employment, sexual function, fertility, and pregnancy must not be overlooked, as they have a direct impact on the liver recipient's quality of life. This review summarizes the latest data in long-term outcome after liver transplantation. Mt Sinai J Med 79:169189, 2012. (C) 2012 Mount Sinai School of Medicine
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据